PDT Partners LLC acquired a new position in Balchem Co. (NASDAQ:BCPC - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,400 shares of the basic materials company's stock, valued at approximately $598,000.
Several other large investors have also recently made changes to their positions in BCPC. nVerses Capital LLC purchased a new stake in Balchem during the 3rd quarter worth approximately $35,000. GAMMA Investing LLC boosted its holdings in Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company's stock valued at $148,000 after purchasing an additional 356 shares during the period. Blue Trust Inc. grew its stake in Balchem by 642.5% during the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company's stock worth $148,000 after purchasing an additional 726 shares in the last quarter. TD Asset Management Inc purchased a new stake in Balchem during the 2nd quarter worth about $200,000. Finally, Heritage Family Offices LLP acquired a new stake in Balchem in the 2nd quarter valued at about $206,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on BCPC. StockNews.com upgraded shares of Balchem from a "hold" rating to a "buy" rating in a research note on Monday, October 28th. HC Wainwright boosted their target price on shares of Balchem from $185.00 to $190.00 and gave the stock a "buy" rating in a research note on Monday, November 4th.
Check Out Our Latest Stock Analysis on Balchem
Balchem Stock Down 1.7 %
Balchem stock traded down $3.09 during mid-day trading on Tuesday, hitting $177.99. The company had a trading volume of 138,524 shares, compared to its average volume of 128,251. The business has a fifty day moving average of $174.56 and a 200 day moving average of $167.78. The stock has a market cap of $5.79 billion, a price-to-earnings ratio of 47.85, a PEG ratio of 5.41 and a beta of 0.67. Balchem Co. has a 1 year low of $124.34 and a 1 year high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.
About Balchem
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Articles
Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
